SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-027104
Filing Date
2022-05-16
Accepted
2022-05-16 16:11:03
Documents
44
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_pasithea.htm   iXBRL 10-Q 377725
2 CERTIFICATION f10q0322ex31-1_pasithea.htm EX-31.1 9656
3 CERTIFICATION f10q0322ex31-2_pasithea.htm EX-31.2 9608
4 CERTIFICATION f10q0322ex32-1_pasithea.htm EX-32.1 3996
5 CERTIFICATION f10q0322ex32-2_pasithea.htm EX-32.2 4047
  Complete submission text file 0001213900-22-027104.txt   2956174

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ktta-20220331.xsd EX-101.SCH 30842
7 XBRL CALCULATION FILE ktta-20220331_cal.xml EX-101.CAL 18888
8 XBRL DEFINITION FILE ktta-20220331_def.xml EX-101.DEF 169233
9 XBRL LABEL FILE ktta-20220331_lab.xml EX-101.LAB 329373
10 XBRL PRESENTATION FILE ktta-20220331_pre.xml EX-101.PRE 176552
38 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_pasithea_htm.xml XML 276068
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40804 | Film No.: 22929053
SIC: 2834 Pharmaceutical Preparations